Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Farmers Insurance
US Department of Justice
Daiichi Sankyo
US Army
Boehringer Ingelheim
Citi
Colorcon

Generated: November 17, 2018

DrugPatentWatch Database Preview

SODIUM PHENYLBUTYRATE Drug Profile

« Back to Dashboard

When do Sodium Phenylbutyrate patents expire, and when can generic versions of Sodium Phenylbutyrate launch?

Sodium Phenylbutyrate is a drug marketed by Par Pharm, Sigmapharm Labs Llc, and Alvogen Malta. and is included in four NDAs.

The generic ingredient in SODIUM PHENYLBUTYRATE is sodium phenylbutyrate. There are one thousand four hundred and fifty-four drug master file entries for this compound. Four suppliers are listed for this compound. Additional details are available on the sodium phenylbutyrate profile page.

Drug patent expirations by year for SODIUM PHENYLBUTYRATE
Pharmacology for SODIUM PHENYLBUTYRATE
Synonyms for SODIUM PHENYLBUTYRATE
1716-12-7
1821-12-1 (Parent)
2686-71-7
4-Benzenebutyric acid
4-PB
4-Phenylbutyrate, Na
4-phenylbutyric acid sodium
4-Phenylbutyric Acid Sodium Salt
4-phenylbutyric acid, sodium salt
4PBA
A4107
AB0013057
AC1L1JY9
AC1Q1V7N
AC1Q1V7P
AK-93011
AKOS006344763
AKOS015967141
Ammonaps
Ammonapse
AN-49757
AS-13914
Benzenebutanoic acid, sodium salt
BG0653
Buphenyl
Buphenyl (TN)
C10H11NaO2
C10H12O2.Na
CAS-1716-12-7
CCG-213730
CHEBI:75316
CHEMBL1746
CMK-304
CS-1397
CS0031
CTK4F8662
D05868
D0P2GK
DSSTox_CID_20948
DSSTox_GSID_40948
DSSTox_RID_79606
DTXSID7040948
EL-532
FT-0619402
H454
HMS2089B22
HMS3269N07
HMS3652K18
HY-15654
I01-7248
IN1087
J-010746
J-524277
KS-00000H29
LP077289
LS-173641
Lunaphen
M-2491
MFCD00800247
MolPort-003-986-518
NaPb
natrium-4-phenylbutanoat
NCGC00018113-03
NCGC00018113-07
NCGC00167830-01
NSC 657802
NT6K61736T
OR023628
phenyl n-butyrate sodium salt
Phenylbutyric acid sodium salt
RL02207
s4125
SCHEMBL125792
Sodium 4-phenyibutyrate (cancer), MacroChem/Access
sodium 4-phenylbutanoate
Sodium 4-phenylbutyrate
Sodium 4-Phenylbutyrate (Buphenyl)
Sodium 4-phenylbutyrate (cancer), Virium/ Somanta
Sodium 4-phenylbutyrate (cancer), Virium/Access Pharmaceuticals
Sodium 4-phenylbutyrate, Elan
Sodium 4-phenylbutyrate, Ucyclyd
Sodium phenylbutyrate (cancer), MacroChem/Access
Sodium phenylbutyrate (cancer), Virium/ Somanta
Sodium phenylbutyrate (cancer), Virium/Access Pharmaceuticals
Sodium phenylbutyrate (JAN/USAN)
Sodium phenylbutyrate [USAN:BAN]
Sodium phenylbutyrate [USAN]
Sodium phenylbutyrate, >=98% (HPLC)
Sodium phenylbutyrate, Elan
Sodium phenylbutyrate, European Pharmacopoeia (EP) Reference Standard
Sodium phenylbutyrate, Medicis
Sodium phenylbutyrate, Ucyclyd
Sodium phenylbutyrate, United States Pharmacopeia (USP) Reference Standard
sodium;4-phenylbutanoate
ST51052176
TL8001350
Tox21_110826
Tox21_110826_1
TriButyrate
UNII-NT6K61736T
VP-101
VPZRWNZGLKXFOE-UHFFFAOYSA-M

US Patents and Regulatory Information for SODIUM PHENYLBUTYRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm SODIUM PHENYLBUTYRATE sodium phenylbutyrate POWDER;ORAL 203918-001 Jun 15, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Par Pharm SODIUM PHENYLBUTYRATE sodium phenylbutyrate TABLET;ORAL 204395-001 Apr 15, 2016 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Sigmapharm Labs Llc SODIUM PHENYLBUTYRATE sodium phenylbutyrate POWDER;ORAL 202819-001 Mar 22, 2013 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Alvogen Malta SODIUM PHENYLBUTYRATE sodium phenylbutyrate TABLET;ORAL 090910-001 Nov 18, 2011 AB RX No No ➤ Try a Free Trial ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
QuintilesIMS
Farmers Insurance
US Department of Justice
Daiichi Sankyo
US Army
Boehringer Ingelheim
Citi
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.